Skip to content

Comparison of Morphological and Radiological Data in Patients With Urolithiasis

Comparison of the Morphological Picture of the Renal Parenchyma With the Results of Mathematical Analysis of Intrarenal Transport of Contrast Medium in Computed Tomography in Patients With Urolithiasis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04506723
Enrollment
40
Registered
2020-08-10
Start date
2020-04-30
Completion date
2021-12-31
Last updated
2021-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Brief summary

The aim of the study was to compare the ultrastructural changes in the renal parenchyma with the results of postprocessing CT analysis with contrast enhancement in patients with urolithiasis.

Interventions

PROCEDUREPercutaneous Nephrolithotomy

PCNL will be carried out in accordance with the standards and capabilities of the medical center. After the procedure pathomorphological data of the renal parenchyma will be assessed

PROCEDUREPartial nephrectomy

Partial nephrectomy will be carried out in accordance with the standards and capabilities of the medical center. After the procedure pathomorphological data of the renal parenchyma will be assessed

Nephrectomy will be carried out in accordance with the standards and capabilities of the medical center. After the procedure pathomorphological data of the renal parenchyma will be assessed

Sponsors

I.M. Sechenov First Moscow State Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

for experimental group: 1. Men and women \>18 years and \<45 years old; 2. Established diagnosis of urolithiasis that does not interfere with the processes of urodynamics (there is no expansion of the overlying urinary tract); 3. Planned surgery - percutaneous nephrolithotripsy; 4. Stone size up to 20 mm., Patients with multiple small two-sided stones; 5. Patients with CT of the kidneys with contrast enhancement performed according to the required protocol.

Exclusion criteria

for experimental group: 1. Age \< 18 years old or ASA\> 3; 2. With single kidney; 3. Patients with coral stones; 4. The presence of concomitant systemic pathology (DM, AH), as well as kidney disease (glomerulonephritis), which can change the state of the renal parenchyma; 5. A history of injuries and surgical interventions on the kidneys, urinary tract, renal vessels; 6. Taking nephrotropic drugs; 7. Systemic intake of nephrotoxic drugs; 8. Severe general somatic condition, making the operation impossible; 9. Pregnancy. Inclusion Criteria for control group: 1. Men and women \>18 years and \<45 years old; 2. Absence of urolithiasis in the patient's anamnesis and in his family history; 3. Renal tumors which have undergone partial nephrectomy or nephrectomy; 4. Patients with CT renal data with contrast enhancement, performed according to the required protocol.

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the features of interrenal transport of contrast agent and the structural state of the renal tissue1 monthThe data of 3D analysis of CT of the kidneys in patients with urolithiasis

Secondary

MeasureTime frameDescription
To assess the features of the morphological structure of glomeruli, tubules, perivascular and interstitial spaces of renal tissue in patients with urolithiasis2 weeksThe assessment will be based on intraoperative biopsy

Countries

Russia

Contacts

Primary ContactDmitry Fiev, M.D., Ph.D.
fiev@mail.ru+79265690949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026